In this episode, obesity medicine specialist and OMA Clinical Education Director, Nicholas Pennings, DO, FOMA, Dipl. ABOM interviews Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC, a highlighted speaker from Overcoming Obesity 2020 – Virtual, about new pharmaceutical agents in development to treat obesity. Topics covered include why anti-obesity medicines may be necessary in treatment, treatment targets and efficacy of newer pharmaceutical agents, role of combination medications in treatment, and a discussion about stigma and bias around anti-obesity medications.
You can access more information about Obesity Medicine podcasts and other resources from the clinical leader in Obesity Medicine at www.obesitymedicine.org/podcasts.
Episode Guests
Nicholas Pennings, DO, FOMA, Dipl. ABOM
Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC
Resources Mentioned
In this episode, Obesity Medicine Specialist and OMA Clinical Education Director Dr. Nicholas Pennings joins NP Obesity Treatment Center owner Dr. Angela Golden to...
In this episode, Obesity Medicine Specialist and OMA Clinical Education Director Nicholas Pennings, DO, FOMA, FACOFP, and John Jakicic, PhD, discuss the importance of...
In episode two of our four-part Advocacy series, Dr. Nicholas Pennings, an Obesity Medicine Specialist and Clinical Education Director at OMA, engages in a...